ArticleGerontology & geriatric medicine

Efficacy and Safety of Elbasvir/Grazoprevir in Hepatitis C Virus GT1- and GT4-Infected People Aged 65 Years or Older.

Steven Flamm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.